blade, i agree that the market is discounting many details... which it tends to do as the fast money starts rolling. once it settles i suspect we'll see some nice movement.
There are no milestone payments pursuant to FDA approval, but MNTA receives a roughly 45% share of Lovenox net profits as long as there is only one generic on the market.
Market Data 
Markets 
AI
